NCT04805099 Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease Status COMPLETED Phase N/A
NCT04789993 Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up Status UNKNOWN Phase N/A
NCT04786821 Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis Status COMPLETED Phase NA
NCT04691232 Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT04684602 Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Status RECRUITING Phase PHASE1/PHASE2
NCT04665232 Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases Status COMPLETED Phase N/A
NCT04663204 A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04561557 Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System Status RECRUITING Phase EARLY_PHASE1
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases Status COMPLETED Phase N/A
NCT04298749 Safety and Tolerability of GX-P1 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT04297592 Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Status ENROLLING_BY_INVITATION Phase PHASE4
NCT04293718 Acquired Chronic Erosive Gingivitis: Clinical Relevance of Papillary Gingival Biopsy Status COMPLETED Phase N/A
NCT04274257 A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis Status COMPLETED Phase PHASE2/PHASE3
NCT04127747 Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE4